# Pablo Francisco Beltran Sanchez · 66-41 · ECUADOR — FDA import alert red lists: firms subject to detention without physical examination

For Pablo Francisco Beltran Sanchez · 66-41 · ECUADOR, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is ECUADOR; product is Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) | Sol Andino Naturally Health; Melissa Leaf (Toronjil) | Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) | Sol Andino Naturally Healthy; Plantain Grain (Llanten) | Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) | Sol Andino Naturally Health; Melissa Leaf (Toronjil) | Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) | Sol Andino Naturally Healthy; Plantain Grain (Llanten) | Sol Andino Naturally Healthy; Plantain Grain (Llanten) | Sol Andino Naturally Healthy; Plantain Grain (Llanten) | Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) | Sol Andino Naturally Health; Melissa Leaf (Toronjil) | Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) | Sol Andino Naturally Health; Melissa Leaf (Toronjil) | Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) | Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) | Sol Andino Naturally Healthy; Plantain Grain (Llanten); product code is 31 K - - 99 Tea, N.E.C. | 31 K - - 99 Tea, N.E.C. | 31 K - - 99 Tea, N.E.C. | 31 K - - 99 Tea, N.E.C. | 31 N - - 99 Novelty Teas, N.E.C. | 31 N - - 99 Novelty Teas, N.E.C. | 31 N - - 99 Novelty Teas, N.E.C. | 31 N - - 99 Novelty Teas, N.E.C. | 54 E - - 55 Plantain (e.g., weed), (Herbal & Botanical Teas) | 54 E - - 99 Herbals & Botanical Teas, N.E.C. | 54 E - - 99 Herbals & Botanical Teas, N.E.C. | 54 E - - 99 Herbals & Botanical Teas, N.E.C. | 54 E - - 99 Herbals & Botanical Teas, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 06/06/2024; address is Eloy Alfaro Lt 4 & Panamericana Norte , Quito, Pichincha ECUADOR, verified against its source on 2026-09-16.

- **Firm:** Pablo Francisco Beltran Sanchez _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** ECUADOR _(verified: appears in the quote below)_
- **Address:** Eloy Alfaro Lt 4 & Panamericana Norte , Quito, Pichincha ECUADOR _(verified: appears in the quote below)_
- **Date published:** 06/06/2024 _(verified: appears in the quote below)_
- **Product code:** 31 K - - 99 Tea, N.E.C. | 31 K - - 99 Tea, N.E.C. | 31 K - - 99 Tea, N.E.C. | 31 K - - 99 Tea, N.E.C. | 31 N - - 99 Novelty Teas, N.E.C. | 31 N - - 99 Novelty Teas, N.E.C. | 31 N - - 99 Novelty Teas, N.E.C. | 31 N - - 99 Novelty Teas, N.E.C. | 54 E - - 55 Plantain (e.g., weed), (Herbal & Botanical Teas) | 54 E - - 99 Herbals & Botanical Teas, N.E.C. | 54 E - - 99 Herbals & Botanical Teas, N.E.C. | 54 E - - 99 Herbals & Botanical Teas, N.E.C. | 54 E - - 99 Herbals & Botanical Teas, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_
- **Product:** Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) | Sol Andino Naturally Health; Melissa Leaf (Toronjil) | Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) | Sol Andino Naturally Healthy; Plantain Grain (Llanten) | Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) | Sol Andino Naturally Health; Melissa Leaf (Toronjil) | Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) | Sol Andino Naturally Healthy; Plantain Grain (Llanten) | Sol Andino Naturally Healthy; Plantain Grain (Llanten) | Sol Andino Naturally Healthy; Plantain Grain (Llanten) | Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) | Sol Andino Naturally Health; Melissa Leaf (Toronjil) | Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) | Sol Andino Naturally Health; Melissa Leaf (Toronjil) | Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) | Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) | Sol Andino Naturally Healthy; Plantain Grain (Llanten) _(verified: each item appears in the quote below)_
- **FDA notes:** The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anticancer properties… used to treat infections… herpes, inflammation of the nose and throat and parasitic infections such as lice.” | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “For treating problems related to nerves.” | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anti-bacterial properties that help prevent further microbial growth in the intestines… gastroenteritis and diarrhea”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Applied to wounds. . .and sores in order to facilitate healing and prevent infection. . .an anti-microbial agent… which reduces pain”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anticancer properties… used to treat infections… herpes, inflammation of the nose and throat and parasitic infections such as lice.” | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “For treating problems related to nerves.” | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anti-bacterial properties that help prevent further microbial growth in the intestines… gastroenteritis and diarrhea”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Applied to wounds. . .and sores in order to facilitate healing and prevent infection. . .an anti-microbial agent… which reduces pain”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Applied to wounds. . .and sores in order to facilitate healing and prevent infection. . .an anti-microbial agent… which reduces pain”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Applied to wounds. . .and sores in order to facilitate healing and prevent infection. . .an anti-microbial agent… which reduces pain”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anticancer properties… used to treat infections… herpes, inflammation of the nose and throat and parasitic infections such as lice.” | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “For treating problems related to nerves.” | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anti-bacterial properties that help prevent further microbial growth in the intestines… gastroenteritis and diarrhea”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “For treating problems related to nerves.” | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anti-bacterial properties that help prevent further microbial growth in the intestines… gastroenteritis and diarrhea”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anticancer properties… used to treat infections… herpes, inflammation of the nose and throat and parasitic infections such as lice.” | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Applied to wounds. . .and sores in order to facilitate healing and prevent infection. . .an anti-microbial agent… which reduces pain”. _(verified: each item appears in the quote below)_

## What the source says

> Pablo Francisco Beltran Sanchez Date Published : 06/06/2024 Eloy Alfaro Lt 4 & Panamericana Norte , Quito, Pichincha ECUADOR 31 K - - 99 Tea, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anticancer properties… used to treat infections… herpes, inflammation of the nose and throat and parasitic infections such as lice.” 31 K - - 99 Tea, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Health; Melissa Leaf (Toronjil) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “For treating problems related to nerves.” 31 K - - 99 Tea, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anti-bacterial properties that help prevent further microbial growth in the intestines… gastroenteritis and diarrhea”. 31 K - - 99 Tea, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Plantain Grain (Llanten) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Applied to wounds. . .and sores in order to facilitate healing and prevent infection. . .an anti-microbial agent… which reduces pain”. 31 N - - 99 Novelty Teas, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anticancer properties… used to treat infections… herpes, inflammation of the nose and throat and parasitic infections such as lice.” 31 N - - 99 Novelty Teas, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Health; Melissa Leaf (Toronjil) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “For treating problems related to nerves.” 31 N - - 99 Novelty Teas, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anti-bacterial properties that help prevent further microbial growth in the intestines… gastroenteritis and diarrhea”. 31 N - - 99 Novelty Teas, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Plantain Grain (Llanten) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Applied to wounds. . .and sores in order to facilitate healing and prevent infection. . .an anti-microbial agent… which reduces pain”. 54 E - - 55 Plantain (e.g., weed), (Herbal & Botanical Teas) Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Plantain Grain (Llanten) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Applied to wounds. . .and sores in order to facilitate healing and prevent infection. . .an anti-microbial agent… which reduces pain”. 54 E - - 99 Herbals & Botanical Teas, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Plantain Grain (Llanten) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Applied to wounds. . .and sores in order to facilitate healing and prevent infection. . .an anti-microbial agent… which reduces pain”. 54 E - - 99 Herbals & Botanical Teas, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anticancer properties… used to treat infections… herpes, inflammation of the nose and throat and parasitic infections such as lice.” 54 E - - 99 Herbals & Botanical Teas, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Health; Melissa Leaf (Toronjil) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “For treating problems related to nerves.” 54 E - - 99 Herbals & Botanical Teas, N.E.C. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anti-bacterial properties that help prevent further microbial growth in the intestines… gastroenteritis and diarrhea”. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/06/2024 Desc: Sol Andino Naturally Health; Melissa Leaf (Toronjil) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “For treating problems related to nerves.” 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Guava Leaf (Hoja de Guayaba) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anti-bacterial properties that help prevent further microbial growth in the intestines… gastroenteritis and diarrhea”. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Soursop Leaf (Hoja de Guanabana) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Have anticancer properties… used to treat infections… herpes, inflammation of the nose and throat and parasitic infections such as lice.” 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/06/2024 Desc: Sol Andino Naturally Healthy; Plantain Grain (Llanten) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its label includes claims such as: “Applied to wounds. . .and sores in order to facilitate healing and prevent infection. . .an anti-microbial agent… which reduces pain”.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).